Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesArtificial IntelligenceBeyond the algorithm: Embedding AI into imaging workflowsIntegrating AI into workflow is the defining factor that determines whether a tool delivers real value or fades into irrelevance, writes market analyst Umar Ahmed.Radiology EducationUkrainian radiologists train, collaborate throughout warMRICE MRI-based radiomics model captures DEB TACE-induced tumor changesCTImaging casts new light on war injuriesWomens ImagingHybrid AI reading shows success in breast cancer screening